Team discussing drug development project management next to computers with dashboards

Quality & Compliance

7 Reasons Projects Fail (And How to Ensure Success)

Leadership at drug and devices companies are continually overwhelmed with the constant balance of driving daily work, managing resources, and addressing unplanned emergencies. This balance is then...

Digital Transformation

Best Practices for Veeva Vault Software Upgrades & Release Management

Across biotech startups and global pharmaceutical companies alike, Veeva Vault continues to expand market share. With 1,300+ customers, Veeva Systems is one of the largest providers of cloud...

Meet the Expert: Long Tan (Tom)

Meet the Expert: Long Tan [Tom]

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Meet the Expert: Amol Yelgaonkar

Meet the Expert: Amol Yelgaonkar

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

CRISPR drug development project management pathogenic DNA

Quality & Compliance

Key Challenges of CRISPR Drug Development Project Management

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a gene-editing technology that holds enormous promise for treating genetic diseases. However, developing CRISPR-based drugs is...

Meet the Expert: Ana Ming

Meet the Expert: Ana Ming

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Specialty drug development project management scheduling concepts with ProPharma's flywheel overlaid

Quality & Compliance

Key Challenges of Specialty Pharma Drug Development Project Management

Specialty pharma companies are focused on developing drugs for niche markets, such as rare diseases, cancer, and other complex conditions. These drugs often require significant investment in research...

Meet the Expert: Collin Freeman

Meet the Expert: Collin Freeman

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Meet the Expert: Tiffany Rice

Meet the Expert: Tiffany Rice

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Clinical Research Solutions

Meet the Expert: Alexis O'temro

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Meet the Expert: Dr. David Crome

Meet the Expert: Dr. David Crome

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Graphs and charts displaying on a modern tablet device.

7 Considerations When Implementing and Maintaining a Research Data Management Platform

Investments in digital transformations are expected to grow from $594.5 billion USD in 2022 to $1.548.9 billion USD by 2027, with the goal of improving the generation, collation, storage, and...

Meet the Expert: Amy Scalise

Clinical Research Solutions

Meet the Expert: Amy Scalise

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Sophisticated pharmaceutical manufacturing machines in progress.

Revised Annex 1, EudraLex Volume 4: Deadline to Comply: August 2023

The deadline to comply with the revised EudraLex Volume 4, Annex 1 is August 25th, 2013. Only for a sole point (point 8.123: "product transfer/loading/unloading areas for lyophilizers“) a later...

Healthcare provider working on tablet device

Clinical Research Solutions

The Importance of Responding to FDA 483 Observations

This article has been updated since its original publication date. The FDA has an established policy that allows companies 15 days to respond in writing to the FDA after issuance of a 483...

Gloved hand writing on a clipboard.

Clinical Research Solutions

FDA Form 483: Common Pitfalls You Can Avoid

This article has been updated since its original publication date. FDA Form 483 requires a written response in which you must make it clear that you are taking the observations, and your...